English

CENTAUR PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2001-05-14

11 filing records in this dataset, filed from 1998-11-13 to 2001-05-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.3 million USD

2001-03-31 · USD

Exact inputs and evidence

Revenue: 1304000 USD Source

Operating margin

-297.47%

2001-03-31 · %

Exact inputs and evidence

Operating Income: -3879000 USD Source
Revenue: 1304000 USD Source

Operating cash flow

-2.65 million USD

2001-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -2653000 USD Source

Free cash flow

-5.04 million USD

2001-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -2653000 USD Source
Capital Expenditure: 2387000 USD Source

Cash and cash equivalents: 10.7 million USD 2001-03-31 Source
Exact value

10710000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-15.1 million USD

2000-04-01 – 2001-03-31

Exact inputs and evidence

Net income: -3464000 USD · 2000-04-01 – 2000-06-30 Source
Net income: -3371000 USD · 2000-07-01 – 2000-09-30 Source
Net income: -13941000 USD · 2000-01-01 – 2000-12-31 Source
Net income: -9479000 USD · 2000-01-01 – 2000-09-30 Source
Net income: -3843000 USD · 2001-01-01 – 2001-03-31 Source

Operating cash flow

-13.7 million USD

2000-04-01 – 2001-03-31

Exact inputs and evidence

Operating cash flow: -6697000 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -1389000 USD · 2000-01-01 – 2000-03-31 Source
Operating cash flow: -10396000 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -6697000 USD · 2000-01-01 – 2000-06-30 Source
Operating cash flow: -12412000 USD · 2000-01-01 – 2000-12-31 Source
Operating cash flow: -10396000 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -2653000 USD · 2001-01-01 – 2001-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-05-14.

Financial data available through: 2000-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 5 of 11 periods available· newest 2000-12-31
Net income: 5 of 11 periods available· newest 2000-12-31
Operating cash flow: 4 of 11 periods available· newest 2000-12-31
Capital expenditure: 4 of 11 periods available· newest 2000-12-31
Total assets: 5 of 11 periods available· newest 2000-12-31
Total liabilities: 4 of 11 periods available· newest 2000-12-31
Current assets: 4 of 11 periods available· newest 2000-12-31
Current liabilities: 5 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 656,000

Prior period

−USD 13.29 million

1999-01-01 – 1999-12-31
Current period

−USD 13.94 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-13941000 − -13285000 = -656000 USD

-13285000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-13941000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CENTAUR PHARMACEUTICALS INC · 2000-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Year-over-year change in Net income: -656000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13941000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3488 Input fundies:NetIncome: -13285000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3488
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 3.29 million

Prior period

−USD 9.12 million

1999-01-01 – 1999-12-31
Current period

−USD 12.41 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-12412000 − -9122000 = -3290000 USD

-9122000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-12412000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CENTAUR PHARMACEUTICALS INC · 2000-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Year-over-year change in Operating cash flow: -3290000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -12412000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3506 Input fundies:OperatingCashFlow: -9122000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3506
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+15.8%

Prior period

USD 562,000

1999-01-01 – 1999-12-31
Current period

USD 651,000

2000-01-01 – 2000-12-31

Exact inputs and evidence

651000 − 562000 = 89000 USD

562000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
651000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CENTAUR PHARMACEUTICALS INC · 2000-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Year-over-year change in Capital expenditure: 89000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 651000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3510 Input fundies:CapitalExpenditure: 562000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3510
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1996 1996-01-01 – 1996-12-31	USD 2.95 million Exact value Exact value: 2945000 USD 1996-01-01 – 1996-12-31: 2945000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CENTAUR PHARMACEUTICALS INC · 1996-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Net Income: 2945000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2945000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-99-000971.txt#3879 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1997 1997-01-01 – 1997-12-31	−USD 7.23 million Exact value Exact value: -7232000 USD 1997-01-01 – 1997-12-31: -7232000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CENTAUR PHARMACEUTICALS INC · 1997-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Net Income: -7232000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7232000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-00-001761.txt#3929 The citation records this snapshot. The page link may show a newer release later.	−USD 6.17 million Exact value Exact value: -6173000 USD 1997-01-01 – 1997-12-31: -6173000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CENTAUR PHARMACEUTICALS INC · 1997-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Operating Cash Flow: -6173000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6173000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-00-001761.txt#3946 The citation records this snapshot. The page link may show a newer release later.	USD 7.54 million Exact value Exact value: 7542000 USD 1997-01-01 – 1997-12-31: 7542000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CENTAUR PHARMACEUTICALS INC · 1997-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Capital Expenditure: 7542000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7542000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-00-001761.txt#3949 The citation records this snapshot. The page link may show a newer release later.	−USD 13.72 million Calculation and evidence -6173000 − 7542000 USD Exact free cash flow: -13715000 USD 1997-01-01 – 1997-12-31: -6173000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 7542000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CENTAUR PHARMACEUTICALS INC · 1997-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Free cash flow: -13715000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6173000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-00-001761.txt#3946 Input fundies:CapitalExpenditure: 7542000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-00-001761.txt#3949 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 10.69 million Exact value Exact value: -10685000 USD 1998-01-01 – 1998-12-31: -10685000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CENTAUR PHARMACEUTICALS INC · 1998-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Net Income: -10685000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10685000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3488 The citation records this snapshot. The page link may show a newer release later.	−USD 7.13 million Exact value Exact value: -7132000 USD 1998-01-01 – 1998-12-31: -7132000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CENTAUR PHARMACEUTICALS INC · 1998-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Operating Cash Flow: -7132000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7132000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3506 The citation records this snapshot. The page link may show a newer release later.	USD 3.47 million Exact value Exact value: 3471000 USD 1998-01-01 – 1998-12-31: 3471000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CENTAUR PHARMACEUTICALS INC · 1998-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Capital Expenditure: 3471000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3471000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3510 The citation records this snapshot. The page link may show a newer release later.	−USD 10.6 million Calculation and evidence -7132000 − 3471000 USD Exact free cash flow: -10603000 USD 1998-01-01 – 1998-12-31: -7132000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 3471000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CENTAUR PHARMACEUTICALS INC · 1998-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Free cash flow: -10603000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7132000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3506 Input fundies:CapitalExpenditure: 3471000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3510 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 13.29 million Exact value Exact value: -13285000 USD 1999-01-01 – 1999-12-31: -13285000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CENTAUR PHARMACEUTICALS INC · 1999-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Net Income: -13285000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13285000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3488 The citation records this snapshot. The page link may show a newer release later.	−USD 9.12 million Exact value Exact value: -9122000 USD 1999-01-01 – 1999-12-31: -9122000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CENTAUR PHARMACEUTICALS INC · 1999-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Operating Cash Flow: -9122000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9122000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3506 The citation records this snapshot. The page link may show a newer release later.	USD 562,000 Exact value Exact value: 562000 USD 1999-01-01 – 1999-12-31: 562000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CENTAUR PHARMACEUTICALS INC · 1999-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Capital Expenditure: 562000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 562000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3510 The citation records this snapshot. The page link may show a newer release later.	−USD 9.68 million Calculation and evidence -9122000 − 562000 USD Exact free cash flow: -9684000 USD 1999-01-01 – 1999-12-31: -9122000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 562000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CENTAUR PHARMACEUTICALS INC · 1999-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Free cash flow: -9684000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9122000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3506 Input fundies:CapitalExpenditure: 562000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3510 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 13.94 million Exact value Exact value: -13941000 USD 2000-01-01 – 2000-12-31: -13941000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CENTAUR PHARMACEUTICALS INC · 2000-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Net Income: -13941000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13941000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3488 The citation records this snapshot. The page link may show a newer release later.	−USD 12.41 million Exact value Exact value: -12412000 USD 2000-01-01 – 2000-12-31: -12412000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CENTAUR PHARMACEUTICALS INC · 2000-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Operating Cash Flow: -12412000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12412000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3506 The citation records this snapshot. The page link may show a newer release later.	USD 651,000 Exact value Exact value: 651000 USD 2000-01-01 – 2000-12-31: 651000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CENTAUR PHARMACEUTICALS INC · 2000-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Capital Expenditure: 651000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 651000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3510 The citation records this snapshot. The page link may show a newer release later.	−USD 13.06 million Calculation and evidence -12412000 − 651000 USD Exact free cash flow: -13063000 USD 2000-01-01 – 2000-12-31: -12412000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 651000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CENTAUR PHARMACEUTICALS INC · 2000-12-31 CENTAUR PHARMACEUTICALS INC (edgar:911369) Free cash flow: -13063000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T13:21:10Z Snapshot: c1c1c7a2e9c234c9f8eeddae5dc416c4f05ba55f551639e1bb89a8556b1eaaa8 Dimensions: Consolidated View: https://fundies.io/companies/edgar/911369?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12412000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3506 Input fundies:CapitalExpenditure: 651000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/911369/0001012870-01-001479.txt#3510 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

11 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0000911369, 911369, edgar:911369

CENTAUR PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation